Get Started

IFRX

NASD InflaRx N.V.
Nov 7, 2026 · 5:24 AM ET EOD Market Closed

$1.31 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.31, $0.02 below the day’s high of $1.32

YTD change
+29.21%
vs 20-day SMA
-16.27%
vs 200-day SMA
-20.81%

Price ranges

Previous day
$1.17 $1.32
open $1.22 close $1.31
+$0.09 (+6.97%)
Today
$1.17 $1.32
$1.31
Past week
$1.33 $1.79
from $1.72 now $1.31
-$0.41 (-23.91%)
Past month
$1.29 $1.79
from $1.53 now $1.31
-$0.23 (-14.71%)
This year
$0.80 $2.95
from $1.01 now $1.31
+$0.30 (+29.21%)

Price & Performance

-1.34 (-50.75%) / 6M

$1.19$1.75$2.30$2.85May 7Aug 7Nov 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.5% away from all-time highs of $53.10
  • IFRX is up 29% since the beginning of the year
  • IFRX is up 9% over the past 12 months
  • IFRX is down 15% over the past 1 month
  • 8% of all IFRX investors are betting against IFRX

IFRX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +6.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.022389
Earnings momentum +57.7% Quarterly EPS growth
Quarterly change +57.7%

Valuation

P/E ratio N/A
Enterprise value $69.5M
Beta 3.67

Balance sheet & scale

IncomeN/A
Revenue$-40827.0
Cash$131.1M
Debt$920.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $201.1M

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,354.00 -0.79%
JNJ Johnson & Johnson $276.22 +1.43%
ABBV AbbVie, Inc. $291.31 +1.07%
MRK Merck & Co., Inc. $146.73 -0.14%
RHHBY Roche Holding Ltd Sponsored ADR $59.37 -0.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.